As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.
17 Analysts have issued a Prime Medicine forecast:
17 Analysts have issued a Prime Medicine forecast:
| Jun '25 |
+/-
%
|
||
| Revenue | 4.96 4.96 |
741%
741%
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -197 -197 |
10%
10%
|
|
| EBIT (Operating Income) EBIT | -204 -204 |
9%
9%
|
|
| Net Profit | -199 -199 |
8%
8%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
| Head office | United States |
| CEO | Keith Gottesdiener |
| Employees | 214 |
| Founded | 2019 |
| Website | primemedicine.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


